Higher cost sharing is associated with reduced branded antidepressant initiation among patients trying generic therapy. Dynamic benefit designs could enhance access to branded medications when appropriate.
Lisa Mucha, PhD
Advertisement
Articles by Lisa Mucha, PhD
Advertisement
Latest Updated Articles
- Racial Differences in Switching, Augmentation, and Titration of Lipid-lowering Agents by Medicare/Medicaid Dual-eligible Patients
Published: June 1st 2007 | Updated:
- Cost Sharing and Branded Antidepressant Initiation Among Patients Treated With Generics
Published: April 13th 2018 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
2025 Nobel Prize in Medicine Honors Discoveries Behind Regulatory T Cells
2
FDA Expands Roflumilast Use for Atopic Dermatitis to Children Aged 2 to 5 Years
3
Amgen Direct-to-Patient Program Aims to Expand Access to Evolocumab Amid US Drug Pricing Reforms
4
Mediterranean Diet Improves Psoriasis Severity, Study Finds
5
